In recent years, there have been increasing concerns over the risk of cancer from the Medtronic Infuse bone growth protein. The product liability lawyers at Saiontz & Kirk, P.A. are evaluating the potential for Medtronic Infuse cancer lawsuits on behalf of individuals diagnosed with: Breast Cancer… Read More
By Austin Kirk
December 14, 2012 | 4 Comments
Medtronic's Infuse BMP has been promoted as an new alternative bone graft product, allowing individuals to avoid harvesting bone from a different part of the body or using donated bone. However, side effects of Medtronic Infuse may cause excessive bone growth, also known as ectopic bone… Read More
By Austin Kirk
September 14, 2012 | 5 Comments
Since the Medtronic Infuse bone graft was approved in 2002, it has been used largely "off-label" during procedures for which it was never approved by the FDA and for which the manufacturer knew there was an increased risk of serious and potentially life-threatening complications. Despite the… Read More
By Harvey Kirk
August 23, 2012 | 2 Comments
More than three years after our lawyers first posted information on this blog about the risk of problems with Medtronic Infuse bone graft surgery, individuals continue to suffer serious and potentially life-threatening injuries. This week, we added new information and resources to our website about potential… Read More
By Austin Kirk
May 7, 2012 | 13 Comments
As a result of false statements which failed to disclose issues with their liquid bone stimulator, a Medtronic Infuse Bone Graft class action lawsuit has been filed by shareholders of Medtronic, Inc. The complaint alleges that Medtronic failed to disclose that a large portion of their… Read More
By Harvey Kirk
December 12, 2008 | 2 Comments
The lawyers at Saiontz & Kirk, P.A. are now evaluating and reviewing the potential for Medtronic Infuse Bone Graft lawsuits on behalf of individuals who received the bone stimulator during a cervical spine fusion, or neck surgery. The use of the Medtronic bone graft in the… Read More
By Austin Kirk
December 4, 2008 | 3 Comments